These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 16845661)
21. Nursing implications for the lifelong management of tuberous sclerosis complex. Agricola K; Tudor C; Krueger D; Franz DN J Neurosci Nurs; 2013 Aug; 45(4):226-42. PubMed ID: 23812052 [TBL] [Abstract][Full Text] [Related]
22. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177 [TBL] [Abstract][Full Text] [Related]
23. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Jozwiak J; Jozwiak S; Oldak M Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102 [TBL] [Abstract][Full Text] [Related]
24. Generation of a conditional disruption of the Tsc2 gene. Hernandez O; Way S; McKenna J; Gambello MJ Genesis; 2007 Feb; 45(2):101-6. PubMed ID: 17245776 [TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Moreno A; Akcakanat A; Munsell MF; Soni A; Yao JC; Meric-Bernstam F Endocr Relat Cancer; 2008 Mar; 15(1):257-66. PubMed ID: 18310292 [TBL] [Abstract][Full Text] [Related]
26. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology. Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811 [TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777 [TBL] [Abstract][Full Text] [Related]
28. The tuberous sclerosis complex: balancing proliferation and survival. Tomasoni R; Mondino A Biochem Soc Trans; 2011 Apr; 39(2):466-71. PubMed ID: 21428921 [TBL] [Abstract][Full Text] [Related]
29. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex. Rensing N; Han L; Wong M Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303 [TBL] [Abstract][Full Text] [Related]
30. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities. Kotulska K; Larysz-Brysz M; Grajkowska W; Jóźwiak J; Włodarski P; Sahin M; Lewin-Kowalik J; Domańska-Pakieła D; Jóźwiak S Pediatr Dev Pathol; 2009; 12(2):89-95. PubMed ID: 17990907 [TBL] [Abstract][Full Text] [Related]
31. Management of epilepsy in tuberous sclerosis complex. Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974 [TBL] [Abstract][Full Text] [Related]
32. Tuberous sclerosis complex: disease modifiers and treatments. Au KS; Ward CH; Northrup H Curr Opin Pediatr; 2008 Dec; 20(6):628-33. PubMed ID: 19005330 [TBL] [Abstract][Full Text] [Related]
33. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex. Mizuguchi M Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684 [TBL] [Abstract][Full Text] [Related]
34. A genetic model to dissect the role of Tsc-mTORC1 in neuronal cultures. Nie D; Sahin M Methods Mol Biol; 2012; 821():393-405. PubMed ID: 22125080 [TBL] [Abstract][Full Text] [Related]
35. CCI-779 plus cisplatin is highly effective against human melanoma in a SCID mouse xenotranplantation model. Thallinger C; Poeppl W; Pratscher B; Mayerhofer M; Valent P; Tappeiner G; Joukhadar C Pharmacology; 2007; 79(4):207-13. PubMed ID: 17377418 [TBL] [Abstract][Full Text] [Related]
36. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27. Rosner M; Freilinger A; Hengstschläger M Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332 [TBL] [Abstract][Full Text] [Related]
37. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987 [TBL] [Abstract][Full Text] [Related]
38. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach. Hengstschläger M; Rosner M; Fountoulakis M; Lubec G Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935 [TBL] [Abstract][Full Text] [Related]
39. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Lam C; Bouffet E; Tabori U; Mabbott D; Taylor M; Bartels U Pediatr Blood Cancer; 2010 Mar; 54(3):476-9. PubMed ID: 19856393 [TBL] [Abstract][Full Text] [Related]
40. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]